Employment |
No Relationships to Disclose |
|
|
Leadership |
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests |
No Relationships to Disclose |
|
|
Honoraria |
No Relationships to Disclose |
|
|
Consulting or Advisory Role |
No Relationships to Disclose |
|
|
Speakers' Bureau |
No Relationships to Disclose |
|
|
Research Funding |
Company: Bristol-Myers Squibb |
Recipient: Your Institution |
Company: Sanofi |
Recipient: Your Institution |
Company: AstraZeneca |
Recipient: Your Institution |
Company: Genentech/Roche |
Recipient: Your Institution |
Company: GlaxoSmithKline |
Recipient: Your Institution |
Company: Novartis |
Recipient: Your Institution |
Company: Merck |
Recipient: Your Institution |
Company: Seattle Genetics |
Recipient: Your Institution |
Company: Lilly |
Recipient: Your Institution |
Company: Amgen |
Recipient: Your Institution |
Company: Bicara |
Recipient: Your Institution |
Company: Zymeworks |
Recipient: Your Institution |
Company: Medicenna |
Recipient: Your Institution |
Company: Bayer |
Recipient: Your Institution |
Company: Takeda |
Recipient: Your Institution |
Company: Gilead Sciences |
Recipient: Your Institution |
Company: LegoChem Biosciences |
Recipient: Your Institution |
Company: LegoChem Biosciences |
Recipient: Your Institution |
|
Patents, Royalties, Other Intellectual Property |
No Relationships to Disclose |
|
|
Expert Testimony |
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses |
No Relationships to Disclose |
|
|
Other Relationship |
No Relationships to Disclose |
|
|
(OPTIONAL) Uncompensated Relationships |
Company: Seagen |
Recipient: You |
Company: Zymeworks |
Recipient: You |
Company: Lilly |
Recipient: You |
Company: Roche/Genentech |
Recipient: You |
Company: Repare Therapeutics |
Recipient: You |
Company: Janssen Oncology |
Recipient: You |
|
(OPTIONAL) Open Payments Link |
No Relationships to Disclose |
|
|